# FDA recall D-1422-2014

> **Healix Infusion Therapy, Inc.** · Class II · drug recall initiated 2014-02-13.

## Product

BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas  77478, NDC 75901-7210-53.

## Reason for recall

Presence of Particulate Matter:  The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.

## Distribution

Texas

## Key facts

- **Recall number:** D-1422-2014
- **Recalling firm:** Healix Infusion Therapy, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-02-13
- **Report date:** 2014-07-16
- **Termination date:** 2016-02-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sugar Land, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1422-2014

## Citation

> AI Analytics. FDA recall D-1422-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1422-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*